High-dose-rate brachytherapy and hypofractionated external beam radiotherapy combined with long-term hormonal therapy for high-risk and very high-risk prostate cancer: outcomes after 5-year follow-up-Reference-Cited by-同舟云学术

High-dose-rate brachytherapy and hypofractionated external beam radiotherapy combined with long-term hormonal therapy for high-risk and very high-risk prostate cancer: outcomes after 5-year follow-up

Published:2013-11-11 Issue:3 Volume:55 Page:509-517
ISSN:0449-3060
Container-title:Journal of Radiation Research
language:en
Short-container-title:Journal of Radiation Research

Author:

Ishiyama H.,Satoh T.,Kitano M.,Tabata K.-i.,Komori S.,Ikeda M.,Soda I.,Kurosaka S.,Sekiguchi A.,Kimura M.,Kawakami S.,Iwamura M.,Hayakawa K.

Publisher

Oxford University Press (OUP)

Subject

Health, Toxicology and Mutagenesis,Radiology, Nuclear Medicine and imaging,Radiation

Link

http://academic.oup.com/jrr/article-pdf/55/3/509/3093194/rrt128.pdf

Reference35 articles.

1. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial

2. Ten-Year Follow-Up of Radiation Therapy Oncology Group Protocol 92-02: A Phase III Trial of the Duration of Elective Androgen Deprivation in Locally Advanced Prostate Cancer

3. Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial

4. The Linear-Quadratic Model Is an Appropriate Methodology for Determining Isoeffective Doses at Large Doses Per Fraction

5. Genitourinary Toxicity After High-Dose-Rate (HDR) Brachytherapy Combined With Hypofractionated External Beam Radiotherapy for Localized Prostate Cancer: An Analysis to Determine the Correlation Between Dose–Volume Histogram Parameters in HDR Brachytherapy and Severity of Toxicity

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The prognostic significance of the clinical T stage and Grade Group in patients with locally advanced prostate cancer treated via high-dose-rate brachytherapy and external beam radiation;International Journal of Clinical Oncology;2023-05-25

2. Radiotherapy-Related Gene Signature in Prostate Cancer;Cancers;2022-10-14

3. Role of Brachytherapy Boost in Clinically Localized Intermediate and High-Risk Prostate Cancer: Lack of Benefit in Patients with Very High-Risk Factors T3b–4 and/or Gleason 9–10;Cancers;2022-06-16

4. The effectiveness of high-dose-rate brachytherapy with external beam radiotherapy for clinically locally advanced and node-positive prostate cancer: long-term results of a retrospective study;International Journal of Clinical Oncology;2021-09-07

5. Novel Prognostic Index of High-Risk Prostate Cancer Using Simple Summation of Very High-Risk Factors;Cancers;2021-07-12